HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[New possibilities in the management of gallbladder calculi].

Abstract
The new nonsurgical methods of treating gallstone disease in gallbladder rely on fragmentation with extracorporeal shock wave lithotripsy (ESWL) and on dissolution of stones with ursodeoxycholic acid (UDCA) and chenodeoxycholic acid (CDCA). Fragmentation alone is usually insufficient for gallbladder stones, and dissolution is only possible for cholesterol stones. Although oral dissolution with or without ESWL is an attractive alternative of surgery, only 25 percent of the patients are candidates for this therapy. Dissolution of the gallbladder stones by topical application of methyl-tertbutyl ether (MTBE) is an other option whose safety is still open to question. Therefore, cholecystectomy will remain the principal treatment for symptomatic gallbladder stones.
AuthorsJ Fehér, L Okolicsányi
JournalOrvosi hetilap (Orv Hetil) Vol. 132 Issue 52 Pg. 2891-6 (Dec 30 1991) ISSN: 0030-6002 [Print] Hungary
Vernacular TitleUj lehetöségek az epehólyagkövesség kezelésében.
PMID1766657 (Publication Type: Journal Article)
Chemical References
  • Cholic Acids
  • Chenodeoxycholic Acid
  • chenodeoxycholate sulfate conjugate
  • ursocholic acid
Topics
  • Chenodeoxycholic Acid (analogs & derivatives, therapeutic use)
  • Cholecystectomy
  • Cholelithiasis (surgery, therapy)
  • Cholic Acids (therapeutic use)
  • Humans
  • Lithotripsy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: